Cargando…
The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease
AIMS: Given the compelling evidence on the effectiveness of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the conventional heart failure population, SGLT2i deserve exploration in systemic right ventricular (sRV) failure. The initial experience with dapagliflozin in sRV failure patients is de...
Autores principales: | Neijenhuis, Ralph M. L., Nederend, Marieke, Jongbloed, Monique R. M., Kiès, Philippine, Rotmans, Joris I., Vliegen, Hubert W., Jukema, J. Wouter, Egorova, Anastasia D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330719/ https://www.ncbi.nlm.nih.gov/pubmed/37435053 http://dx.doi.org/10.3389/fcvm.2023.1093201 |
Ejemplares similares
-
The first experience with sodium‐glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure
por: Egorova, Anastasia D., et al.
Publicado: (2022) -
Atrioventricular Block Necessitating Chronic Ventricular Pacing After Tricuspid Valve Surgery in Patients With a Systemic Right Ventricle: Long-Term Follow-Up
por: Nederend, Marieke, et al.
Publicado: (2022) -
Contemporary Management Strategies of Baffle Leaks in Adults with a Failing Systemic Right Ventricle Late after Atrial Switch: A Case Series and Literature Overview
por: Neijenhuis, Ralph M. L., et al.
Publicado: (2023) -
Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021) -
Potential of eHealth smart technology in optimization and monitoring of heart failure treatment in adults with systemic right ventricular failure
por: Nederend, Marieke, et al.
Publicado: (2021)